These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Somatomedin C in treated acromegaly: poor correlation with growth hormone and clinical response. Stonesifer LD; Jordan RM; Kohler PO J Clin Endocrinol Metab; 1981 Nov; 53(5):931-4. PubMed ID: 7197287 [TBL] [Abstract][Full Text] [Related]
23. Radioimmunoassay of somatomedin B. Application to clinical and physiologic studies. Yalow RS; Hall K; Luft R J Clin Invest; 1975 Jan; 55(1):127-37. PubMed ID: 803217 [TBL] [Abstract][Full Text] [Related]
24. Effect of bromocriptine on serum hormones in acromegaly. Carlson HE; Levin SR; Braunstein GD; Spencer EM; Wilson SE; Hershman JM Horm Res; 1984; 19(3):142-52. PubMed ID: 6425186 [TBL] [Abstract][Full Text] [Related]
25. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol. Gravholt CH; Naeraa RW; Fisker S; Christiansen JS J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336 [TBL] [Abstract][Full Text] [Related]
26. Radioimmunoassayable serum somatomedin B in normal subjects and in patients with acromegaly and pituitary dwarfism: effects of human growth hormone therapy. Wajchenberg BL; Liberman B; Gomes EN; Pieroni RR Horm Metab Res; 1980 Oct; 12(10):516-9. PubMed ID: 7439876 [TBL] [Abstract][Full Text] [Related]
27. Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. Furlanetto RW; Underwood LE; Van Wyk JJ; D'Ercole AJ J Clin Invest; 1977 Sep; 60(3):648-57. PubMed ID: 893668 [TBL] [Abstract][Full Text] [Related]
28. Growth in Turner's syndrome: long term treatment with low dose ethinyl estradiol. Martínez A; Heinrich JJ; Domené H; Escobar ME; Jasper H; Montuori E; Bergadá G J Clin Endocrinol Metab; 1987 Aug; 65(2):253-7. PubMed ID: 3597706 [TBL] [Abstract][Full Text] [Related]
29. Somatomedin-C levels in treated and untreated patients with acromegaly. Roelfsema F; Frölich M; Van Dulken H Clin Endocrinol (Oxf); 1987 Feb; 26(2):137-44. PubMed ID: 3665113 [TBL] [Abstract][Full Text] [Related]
30. [Behavior of blood somatotropin in Turner's syndrome]. Chiodini PG; Liuzzi A; Botalla L Folia Endocrinol; 1971; 24(5):377-82. PubMed ID: 5172226 [No Abstract] [Full Text] [Related]
31. Criteria for the cure of acromegaly: comparison between basal growth hormone and somatomedin C plasma concentrations in active and non-active acromegalic patients. Giannella-Neto D; Wajchenberg BL; Mendonça BB; Almeida SF; Macchione M; Spencer EM J Endocrinol Invest; 1988 Jan; 11(1):57-60. PubMed ID: 3361077 [TBL] [Abstract][Full Text] [Related]
32. Serum thymidine activity and somatomedin-C levels in children and adolescents with Turner's syndrome: effect of chronic estrogen and progestogen replacement therapy. Guidoux S; Bozzola M; Larizza D; Schimpff RM Horm Res; 1986; 24(4):256-62. PubMed ID: 3781484 [TBL] [Abstract][Full Text] [Related]
33. Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor. Thorner MO; Perryman RL; Cronin MJ; Rogol AD; Draznin M; Johanson A; Vale W; Horvath E; Kovacs K J Clin Invest; 1982 Nov; 70(5):965-77. PubMed ID: 6290540 [TBL] [Abstract][Full Text] [Related]
34. Glucose turnover and insulin clearance after growth hormone treatment in girls with Turner's syndrome. Monti LD; Brambilla P; Caumo A; Magni F; Omati S; Nizzoli G; di Natale B; Galli-Kienle M; Cobelli C; Chiumello G; Pozza G Metabolism; 1997 Dec; 46(12):1482-8. PubMed ID: 9439548 [TBL] [Abstract][Full Text] [Related]
35. Decreased metabolic clearance of endogenous growth hormone and specific alterations in the pulsatile mode of growth hormone secretion occur in prepubertal girls with Turner's syndrome. Genentech Collaborative Group. Veldhuis JD; Sotos JF; Sherman BM J Clin Endocrinol Metab; 1991 Nov; 73(5):1073-80. PubMed ID: 1939522 [TBL] [Abstract][Full Text] [Related]
36. Growth hormone treatment in girls with Turner's syndrome. A review of the literature. Wilton P Acta Paediatr Scand; 1987 Mar; 76(2):193-200. PubMed ID: 3296625 [TBL] [Abstract][Full Text] [Related]
37. Glucose tolerance, growth hormone and somatomedin levels in osteosarcoma patients. Adamson U; Broström LA; Efendić S; Hall K Acta Endocrinol (Copenh); 1980 Aug; 94(4):517-22. PubMed ID: 7001830 [TBL] [Abstract][Full Text] [Related]
38. Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid. Póvoa G; Roovete A; Hall K Acta Endocrinol (Copenh); 1984 Dec; 107(4):563-70. PubMed ID: 6083690 [TBL] [Abstract][Full Text] [Related]
39. The frequency of diabetes mellitus in patients with Turner's syndrome and pure gonadal dysgenesis. Blood glucose, plasma insulin and growth hormone level during an oral glucose tolerance test. Nielsen J; Johansen K; Yde H Acta Endocrinol (Copenh); 1969 Oct; 62(2):251-69. PubMed ID: 5394546 [No Abstract] [Full Text] [Related]
40. Growth hormone treatment in Turner's syndrome: short and long-term effects on metabolic parameters. Haeusler G; Frisch H Clin Endocrinol (Oxf); 1992 Mar; 36(3):247-53. PubMed ID: 1563078 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]